1. Home
  2. SUNS vs NORD Comparison

SUNS vs NORD Comparison

Compare SUNS & NORD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunrise Realty Trust Inc.

SUNS

Sunrise Realty Trust Inc.

HOLD

Current Price

$6.96

Market Cap

108.7M

Sector

Real Estate

ML Signal

HOLD

NORD

Nordicus Partners Corporation Common Stock

N/A

Current Price

$3.72

Market Cap

95.5M

ML Signal

N/A

Company Overview

Basic Information
Metric
SUNS
NORD
Founded
2023
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Professional Services
Sector
Real Estate
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
108.7M
95.5M
IPO Year
2024
2005

Fundamental Metrics

Financial Performance
Metric
SUNS
NORD
Price
$6.96
$3.72
Analyst Decision
Buy
Analyst Count
4
0
Target Price
★ $10.25
N/A
AVG Volume (30 Days)
★ 79.8K
35.4K
Earning Date
11-10-2026
07-25-2017
Dividend Yield
★ 17.86%
N/A
EPS Growth
N/A
★ 31.25
EPS
★ 0.54
N/A
Revenue
★ $21,571,434.00
$3,346.00
Revenue This Year
$91.54
N/A
Revenue Next Year
$12.74
N/A
P/E Ratio
$12.43
★ N/A
Revenue Growth
★ 102.96
N/A
52 Week Low
$5.77
$3.38
52 Week High
$10.45
$5.28

Technical Indicators

Market Signals
Indicator
SUNS
NORD
Relative Strength Index (RSI) 54.43 N/A
Support Level $6.20 N/A
Resistance Level $7.90 N/A
Average True Range (ATR) 0.27 0.00
MACD 0.09 0.00
Stochastic Oscillator 80.00 0.00

Price Performance

Historical Comparison
SUNS
NORD

About SUNS Sunrise Realty Trust Inc.

Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS, and debt-like preferred equity securities across CRE asset classes and investment mix to include high-quality multi-family, condominiums, retail, office, hospitality, industrial, mixed-use, and specialty-use real estate. The company's portfolio is concentrated in the Southern U.S.

About NORD Nordicus Partners Corporation Common Stock

Nordicus Partners Corp specializes in developing breakthrough therapeutics for diseases with unmet medical needs. The Company focuses on acquiring and developing drugs from biotech companies in the Nordics, a region known for its scientists, life sciences ecosystem, and drug discoveries and developments. Its current portfolio includes the preclinical biotechnology companies Orocidin A/S, Bio-Convert A/S, and NoviThera ApS. The Company is dedicated to developing breakthrough therapeutics in diseases with unmet medical needs, starting with oral disorders. It operates in the segment focused on developing medicines supporting oral health.

Share on Social Networks: